From paper forms to 400% more MRI referrals. MRA’s digital shift explained
Patients at elevated risk of breast cancer are often missed in routine care and with paper-based high-risk screening programs. Midstate Radiology Associates (MRA) changed that.
In 2021, MRA overhauled its approach with a digital-first platform that standardizes history collection, calculates Tyrer-Cuzick breast cancer risk scores for all patients, and automates guideline-based genetic testing eligibility.
Three years later, the results are clear and significant.
Read this case study to learn how MRA:
In 2021, MRA overhauled its approach with a digital-first platform that standardizes history collection, calculates Tyrer-Cuzick breast cancer risk scores for all patients, and automates guideline-based genetic testing eligibility.
Three years later, the results are clear and significant.
Read this case study to learn how MRA:
- standardized workflows with digital tools, reducing confusion and boosting risk identification
- increased high-risk MRI screening referrals by 400%
- increased genetic testing rates in eligible patients by 60%
Please fill out the form to download the case study.